runx1

Ro24-7429 是一种有效的口服活性 HIV-1 反式激活蛋白 Tat 拮抗剂和一种矮小相关转录因子 1 的抑制剂。Ro24-7429 具有抗 HIV、抗纤维化和抗炎作用。

Ro5-3335 (CBFβ-Runx1 inhibitor II) 是苯二氮化合物，是RUNX1-CBFβ 相互作用抑制剂，可抑制 RUNX1 CBFB 依赖性反式激活，能作为核心结合因子 (CBF) 白血病抑制剂。

RUNX1 ETO tetramerization-IN-1 is a small-molecule inhibitor that specifically targets NHR2 of RUNX1 ETO, effectively inhibiting the tetramerization process. With an EC50 value of 0.25 μM, this compound successfully restores gene expression that has been down-regulated by RUNX1 ETO. Furthermore, RUNX1 ETO tetramerization-IN-1 demonstrates promising anti-leukemic activity by inhibiting the proliferation of SKNO-1 cells dependent on RUNX1 ETO and significantly reducing RUNX1 ETO-associated tumor growth in a mouse model [1] [2] [3].

CBFβ Inhibitor (5-Ethyl-4-(4-methoxy-phenyl)-thiazol-2-ylamine) 是一种细胞渗透性 CBFβ 抑制剂，可抑制其与 Runx1 的结合。

Kartogenin (KGN) 是一种人间充质干细胞分化为软骨细胞的诱导剂(EC50:100 nM)。它能够结合纤维蛋白 A，破坏其与转录因子核心结合因子 β 亚基 (CBFβ) 的相互作用，并通过调节 CBFβ-RUNX1 转录程序，诱导软骨形成，可用于研究骨关节炎。

NSC-140873 is the RUNX1-CBFβ interaction inhibitor.

AI-4-57 Hydrochloride is a ligand to the CBFß. AI-4-57 Hydrochloride is a modest potency inhibitor of the binding of wildtype CBFß to the RUNX1 Runt domain.

AI-10-49 是一种选择性的 CBFβ-SMMHC 与 RUNX1 结合抑制剂(IC50:260 nM)。

WUN40378 is compound first reported in PCT Int. Appl. (2019), WO 201909959, in which it was described as CBFβ-​RUNX1 inhibitor. WUN40378 is very similar to Ro 5-3335 but with an F instead of Cl. WUN40378 is also analog of Ro 24-7429. This product has no formal name at the moment. For the convenience of communication, a temporary code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https: www.medkoo.com page naming).

Kartogenin (KGN) sodium 是一种软骨样组织形成的诱导剂 (EC50: 100 nM)。Kartogenin sodium 通过结合纤维蛋白 A，阻断其与转录因子核心结合因子 β 亚基 (CBFβ) 的作用，并调节 CBFβ-RUNX1 转录程序来诱导软骨形成。此外，Kartogenin sodium 能促进肌腱-骨连接处 (TBJ) 的伤口愈合，因其能刺激胶原蛋白合成。广泛应用于再生医学中的无细胞疗法，Kartogenin sodium 用于软骨再生及保护、腱骨愈合、伤口愈合与肢体发育等方面，同时对骨关节炎 (OA) 的研究也颇具价值。